3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
5
Neoplasms
3
Lymphoma
3
Preleukemia
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Precancerous Conditions
2
Neoplasms by Histologic Type
2
Myelodysplastic Syndromes
2
Multiple Myeloma
2
Lymphoproliferative Disorders
2
Lymphatic Diseases
2
Leukemia, Myeloid, Acute
2
Leukemia, Myeloid
2
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
2
Leukemia, Lymphoid
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Leukemia, Biphenotypic, Acute
2
Leukemia, B-Cell
2
Leukemia
2
Immunoproliferative Disorders
2
Immune System Diseases
2
Hematologic Diseases
2
Esophageal Neoplasms
2
Bone Marrow Diseases
2
Sarcoma
1
Primary Myelofibrosis
1
Pathologic Complete Response
1
Osteosarcoma
1
Neoplasms, Second Primary
1
Neoplasms, Plasma Cell
1
Interventions
Specimen Handling
8
pembrolizumab
7
enfortumab vedotin
7
Magnetic Resonance Spectroscopy
6
avelumab
4
Nivolumab
4
Gemcitabine
3
cabozantinib
2
Ipilimumab
2
Immunoglobulin G
2
Disulfides
2
Cisplatin
2
Carboplatin
2
CTLA-4 Antigen
2
Biopsy
2
vinflunine
1
tremelimumab
1
tocilizumab
1
tamibarotene
1
relatlimab
1
eribulin
1
erdafitinib
1
durvalumab
1
copanlisib
1
atezolizumab
1
Watchful Waiting
1
Standard of Care
1
Propranolol
1
Practice Guidelines as Topic
1
Plasmapheresis
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Ureteral Neoplasms
×
Patient Reported Outcome Measures
×
1 year
×
Clear all
No trials found.